Regulatory 2020-04-03 | Ascelia Pharma’s Nomination Committee proposes election of Lauren Barnes to the Board of Directors PDF Report Presentation Webcast
Regulatory 2020-04-03 | NOTICE OF ANNUAL GENERAL MEETING IN ASCELIA PHARMA AB PDF Report Presentation Webcast
Regulatory 2020-04-01 | Correction to press release regarding in change in number of shares and votes in Ascelia Pharma AB PDF Report Presentation Webcast
Regulatory 2020-03-31 | Change in number of shares and votes in Ascelia Pharma AB PDF Report Presentation Webcast
2020-03-05 | Analysguiden/Carlsquare updates its view on Ascelia Pharma and raises target share price PDF Report Presentation Webcast
Regulatory 2020-03-02 | Issue and repurchase of series C shares for share saving program PDF Report Presentation Webcast
2020-02-20 | Vator Securities: Ascelia Pharma: A rocket roll out is the key to success PDF Report Presentation Webcast
Regulatory 2020-02-19 | First patient enrolled in pivotal Phase III clinical study SPARKLE with lead candidate Mangoral PDF Report Presentation Webcast
Regulatory 2020-02-14 | 2019 year-end financial report: Sites opened for recruitment to the pivotal Phase III study SPARKLE PDF Report Presentation Webcast
2020-02-11 | Ascelia Pharma wins the award for Best Life Science company in Malmö PDF Report Presentation Webcast
2020-01-13 | Five sites now opened in the pivotal Phase III clinical study SPARKLE for lead drug candidate Mangoral PDF Report Presentation Webcast
